NeueHealth, Inc. (NYSE:NEUE) CEO Sells $233,079.34 in Stock

NeueHealth, Inc. (NYSE:NEUEGet Free Report) CEO George Lawrence Mikan III sold 31,798 shares of the firm’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $233,079.34. Following the transaction, the chief executive officer now owns 146,539 shares of the company’s stock, valued at $1,074,130.87. This trade represents a 17.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

George Lawrence Mikan III also recently made the following trade(s):

  • On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The stock was sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Price Performance

Shares of NYSE NEUE opened at $7.33 on Friday. The company has a market cap of $60.73 million, a PE ratio of -0.14 and a beta of 0.57. NeueHealth, Inc. has a 12 month low of $3.79 and a 12 month high of $16.59. The company has a 50-day simple moving average of $5.60 and a 200-day simple moving average of $5.42.

Institutional Investors Weigh In On NeueHealth

Hedge funds and other institutional investors have recently modified their holdings of the company. Renaissance Technologies LLC purchased a new stake in NeueHealth in the second quarter valued at approximately $312,000. Partners Group Holding AG purchased a new stake in NeueHealth in the third quarter valued at approximately $463,000. Deer Management Co. LLC purchased a new stake in NeueHealth in the second quarter valued at approximately $5,436,000. Finally, NEA Management Company LLC purchased a new stake in NeueHealth in the second quarter valued at approximately $14,834,000. 63.88% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada lowered their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Monday, December 9th.

View Our Latest Research Report on NEUE

NeueHealth Company Profile

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Featured Stories

Insider Buying and Selling by Quarter for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.